Starting NuvaRing (etonogestrel/ethinyl estradiol vaginal ring)

Starting NuvaRing

When and how you start using NuvaRing will depend on your health care provider's recommendation and your current birth control method. It is important to talk with your health care provider to make sure you are not pregnant before starting NuvaRing.

How to begin using NuvaRing

As with any birth control, you should talk to your health care provider about your treatment and consult the Patient Information before you start using NuvaRing and each time you get a refill.

See for yourself how to get started.

How to begin using NuvaRing (etonogestrel/ethinyl estradiol vaginal ring)
 

If you are switching to NuvaRing (etonogestrel/ethinyl estradiol vaginal ring) from:

The pill (combination progestin and estrogen)
A patch (combination progestin and estrogen)
A progestin-only method (mini-pill, implant or
injection) or from a progestin-releasing intrauterine system (IUS)
 
 

If you are starting NuvaRing and:

If you are not currently using hormonal birth control
If you are starting NuvaRing (etonogestrel/ethinyl estradiol vaginal ring)
after childbirth
If you had an abortion or miscarriage
 
Save on NuvaRing (etonogestrel/ethinyl estradiol vaginal ring). Eligible patients may save on NuvaRing (terms and conditions and restrictions apply).
 Is NuvaRing (etonogestrel/ethinyl estradiol vaginal ring) for you?

Important Safety Information

Do not use NuvaRing (etonogestrel/ethinyl estradiol vaginal ring) if you smoke cigarettes and are over age 35. Smoking increases your risk of serious heart and blood vessel problems from combination hormonal contraceptives (CHCs) including heart attack, blood clots, or stroke which can be fatal. This risk increases with age and the number of cigarettes smoked.
CONTINUE BELOW

 

Prescription NuvaRing (etonogestrel/ethinyl estradiol vaginal ring) is a flexible birth control vaginal ring used to prevent pregnancy.

Important Safety Information

Do not use NuvaRing if you smoke cigarettes and are over age 35. Smoking increases your risk of serious heart and blood vessel problems from combination hormonal contraceptives (CHCs) including heart attack, blood clots, or stroke which can be fatal. This risk increases with age and the number of cigarettes smoked.

  • The use of a CHC, like NuvaRing, is associated with increased risks of several serious side effects, including blood clots, stroke, or heart attack. NuvaRing is not for women with a history of these conditions or any condition that makes your blood more likely to clot. The risk of getting blood clots may be greater with the type of progestin in NuvaRing than with some other progestins in certain low-dose birth control pills. The risk of blood clots is highest when you first start using CHCs and when you restart the same or different CHC after not using it for a month or more.
  • NuvaRing is also not for women with high blood pressure that medicine can't control; diabetes with kidney, eye, nerve, or blood vessel damage; certain kinds of severe migraine headaches; liver disease or liver tumors; unexplained vaginal bleeding; breast cancer or any cancer that is sensitive to female hormones; or if you are or may be pregnant.
  • NuvaRing does not protect against HIV infection (AIDS) and other sexually transmitted infections.
  • The most common side effects reported by users of NuvaRing are irritation inside your vagina or on your cervix; headache (including migraine); mood changes (including depression); the ring slipping out or causing discomfort; nausea and vomiting; vaginal discharge; weight gain; vaginal discomfort; breast pain, discomfort, or tenderness; painful menstrual periods; abdominal pain; acne; and less sexual desire.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please read the accompanying Patient Information for NuvaRing (etonogestrel/ethinyl estradiol vaginal ring), including the information about the increased risk of serious cardiovascular side effects, especially in women who smoke, and discuss it with your health care provider. The physician Prescribing Information also is available.